Aerie Pharmaceuticals Inc. buy tamam
Start price
07.10.17
/
50%
€47.90
Target price
04.12.17
€61.34
Performance (%)
22.22%
End price
04.12.17
€58.54
Summary
This prediction ended on 04.12.17 with a price of €58.54. The prediction had a final performance of 22.22%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aerie Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by tamam for this prediction
In the thread Aerie Pharmaceuticals Inc. diskutieren
tamam stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
tamam stimmt am 07.10.2017 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.
(Laufzeit überschritten)
Stopped prediction by tamam for Aerie Pharmaceuticals Inc.
Aerie Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.37
04.09.19
04.09.19
€8.00
04.11.21
04.11.21
-37.07%
05.11.21
05.11.21
